The offering is highly dilutive for a micro-cap company with a $3M market cap. Monitor the filing of the resale registration statement and any subsequent selling by investors. The company's cash runway and ability to fund operations without further dilutive raises are key.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 9 $1.63entry
- T+1 · 11h ago +9.82%α +10.18% · $1.79
- T+5 · in 6d Pending
- T+20 · in 28d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Silo Pharma raised approximately $815,000 in net proceeds through a private placement of 136,005 shares of common stock at $1.50 per share and pre-funded warrants for 430,661 shares at $1.4999 per warrant. The proceeds will be used for working capital and general corporate purposes. The offering is dilutive relative to the company's $3M market cap.
Key Financial Metrics
Key Facts
- Issued 136,005 shares of common stock at $1.50 per share
- Issued pre-funded warrants for 430,661 shares at $1.4999 per warrant
- Net proceeds of approximately $815,000 after fees and expenses
- Company market cap is $3M; total potential dilution from shares and warrants is 566,666 shares
- Proceeds to be used for working capital and general corporate purposes
- Private placement closed on November 6, 2026
- Shares and warrants issued under Section 4(a)(2) and Regulation D exemption
- Company agreed to file a resale registration statement within 30 days
Financial Impact
Gross proceeds of approximately $850,000 ($1.50 x 136,005 shares + $1.4999 x 430,661 warrants); net proceeds ~$815,000. Total potential dilution of 566,666 shares against a $3M market cap company.
Risk Factors
- Significant dilution from the issuance of shares and pre-funded warrants relative to current market cap
- Potential near-term selling pressure once the resale registration statement becomes effective
- Company has limited cash runway; may require additional financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-116982 |
| Document: ea031130601ex10-2.htm | 0001213900-26-116982 |
| Document: ea031130601ex4-1.htm | 0001213900-26-116982 |
| Document: ea0311306-8k_silo.htm | 0001213900-26-116982 |
| Document: 0001213900-26-116982-index-headers.html | 0001213900-26-116982 |
| Document: 0001213900-26-116982-index.html | 0001213900-26-116982 |
| Document: 0001213900-26-116982.txt | 0001213900-26-116982 |
Track record
14 reports on SILO
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +71.50% at T+60 after the Jun 30, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 10, 2026today SC 13G/A Neutral 3/10 Entry $1.85 Now $1.79 −3.24% settles Feb 9
- Nov 6, 20264d ago 8-K Bearish 6/10 Viewing Entry $1.63 Now $1.79 −9.82% settles Feb 5
- Oct 14, 202627d ago 8-K Neutral 3/10 Entry $1.20 Now $1.79 +49.17% settles Jan 12
- Oct 2, 20265w ago 8-K Neutral 4/10 Entry $1.49 Now $1.79 +20.13% settles Dec 30
- Sep 18, 20267w ago Press Release Bullish 5/10 Entry $1.84 Now $1.79 −2.72% settles Dec 14
- Aug 7, 202613w ago EFFECT Neutral 4/10 Entry $3.74 to $1.23 Now $1.79 −52.07% ▼ −67.07% −64.80% vs SPY
- Jul 14, 202617w ago Press Release Bullish 4/10 Entry $5.13 to $1.44 Now $1.79 −65.11% ▼ −71.93% −75.31% vs SPY
- Jun 30, 202619w ago DEFA14A Bearish 7/10 Entry $6.21 to $1.77 Now $1.79 +71.18% ▲ +71.50% +75.06% vs SPY
- Jun 3, 202622w ago 8-K Neutral 4/10 Entry $6.11 to $2.54 Now $1.79 −70.70% ▼ −58.43% −60.31% vs SPY
- Jun 1, 202623w ago 8-K Neutral 2/10 Entry $4.99 to $2.59 Now $1.79 −64.12% ▼ −48.09% −49.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers